Mental Health Clinics in Grabill, IN Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Paris Psychological Services,pc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 11307 Notestine Rd, Grabill, IN 46741 Phone: 260-705-2152 Fax: 260-485-4357 |
News Archive
GenomeNext completes whole genome sequencing analysis at unprecedented 1,000 genomes per day
GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today that, through the "Intel Heads In The Clouds Challenge on Amazon Web Services" with support from JHC Technology, and in conjunction with Nationwide Children's Hospital, has benchmarked whole genome sequencing analysis at an unprecedented 1,000 genomes per day.
Weight loss most important factor for improving cardiovascular health in obese OSA patients
Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with a variety of cardiovascular risk factors, including inflammation, insulin resistance, abnormal cholesterol, and high blood pressure. While effective therapies are available for OSA, researchers are still unclear about what interventions are most effective in reducing the burden of risk factors for cardiovascular disease associated with OSA in obese patients.
Research findings may accelerate work to safely control diabetes
For those with diabetes, managing blood sugar is a balancing act - if blood sugar is too high it raises the risk for nerve damage, blindness, kidney failure, and heart trouble, and if too low it can lead to a seizure or unconsciousness.
Chantix and Zyban to get boxed warnings on serious mental health events
The U.S. Food and Drug Administration has announced that it is requiring manufacturers to put a Boxed Warning on the prescribing information for the smoking cessation drugs Chantix (varenicline) and Zyban (bupropion). The warning will highlight the risk of serious mental health events including changes in behavior, depressed mood, hostility, and suicidal thoughts when taking these drugs.
Ramelteon may help chronic insomniacs
Ramelteon, a novel investigational compound under review with the FDA for the treatment of insomnia, reduced the time it took to fall asleep and increased total sleep time in adults with chronic insomnia, according to results from a Phase 3 study presented this week at the 19th Annual Meeting of the Associated Professional Sleep Societies (APSS).
› Verified 5 days ago